Scott E. Pautler, MD, FACS CURRICULUM VITAE

University of Florida
College of Arts and Sciences
Gainesville, FL
Degree: Bachelor of Science
9/73 – 3/77

University of South Florida
College of Medicine
Tampa, FL
Degree:  Doctor of Medicine
7/77 – 6/80

University of South Carolina
Richland Memorial Hospital
Columbia, SC
General Surgery Internship
7/80 – 6/81

University of South Florida
Tampa, FL
Ophthalmology Residency
7/81 – 6/84

Bascom Palmer Eye Institute
University of Miami
Miami, FL
Medical Retina Fellowship
J. Donald M. Gass, M.D.
7/84 – 6/85

Bascom Palmer Eye Institute
University of Miami
Miami, FL
Vitreoretinal Surgery Fellowship
Drs. Norton, Clarkson, Curtin, Blankenship, Flynn 7/85 – 6/86

Phi Eta Sigma Honorary
University of Florida, 1974
Sigma Tau Sigma Honorary
University of Florida, 1975
Alpha Epsilon Delta Honorary
University of Florida, 1975
Who’s Who Among Students in American
Colleges and Universities
University of Florida, 1977
High Honors Graduate
University of Florida, 1977
Outstanding Student Award
University of South Florida
College of Medicine, 1980
Clinical Diagnosis Award
Bascom Palmer Eye Institute
University of Miami, 1986
Curtis D. Benton, Jr., M.D.
Young Ophthalmologist Leadership Award
Florida Society of Ophthalmology
June 6, 1993
The Best Doctors in America
1998-2020
National Register’s Who’s Who in Executives  and Professionals, 2000
Who’s Who in Diabetes Treatment, Education And Research American Diabetes Association, 2001
Castle Connolly Top Doctor, 2017-2021
Achievement Award, American Academy of Ophthalmology 2017
Alumnus of the Year Award University of South Florida Department of Ophthalmology June, 2019

Assistant Clinical Professor
Department of Ophthalmology
University of South Florida
College of Medicine
Tampa, FL
8/86 to 7/92
Associate Clinical Professor
Department of Ophthalmology
University of South Florida
College of Medicine
Tampa, FL
7/92 to 7/2003
Affiliate Associate Professor
Department of Ophthalmology
University of South Florida
College of Medicine
Tampa, FL
8/1/2003-Present

St Joseph’s Hospital:
Department of Ophthalmology
Tampa, FL
-Chairman 7/88 – 12/89
Florida Society of Ophthalmology
-Chairman, Diabetes 2000  1990-98
-Chairman, Public Relations 1993-94
-Executive Committee 1993-94
Tampa Bay Ophthalmological Society
-Secretary/Treasurer 1991-92
-Vice-President 1992-93
-President 1993-94
American Diabetes Association
Florida Affiliate, Inc.
-Program Committee 1992-1995
-Board of Directors 1992-1995
-Vice-President 1993-94
-President 1994-95

Diplomate, National Board of
Medical Examiners (1981)
Diplomate, American Board of
Ophthalmology (1986)
Fellow, American Academy of
Ophthalmology (1986)
Fellow, American College of
Surgeons (1991)

American Medical Association
American Academy of Ophthalmology
American College of Surgeons
Florida Medical Association
Florida Society of Ophthalmology
Hillsborough County Medical Assn.
Tampa Bay Ophthalmological Society
American Association for Ophthalmic
Standardized Echography (past)
International Society of Ophthalmic
Ultrasound (past)
International Society of Ocular Trauma (past) Campo Fluorescein Society (past)
American Society of Retinal Specialists
Gass Fellowship Society

Adventist Hospital (Senior Active)
Tampa, FL

Collaborative Ocular Melanoma Study
Co-Investigator (1989)
Endophthalmitis Vitrectomy Study
Co-Principal Investigator (1989-94)
USF Silicone Oil Study
Co-Principal Investigator (1989-94)
Study of Ocular Complications of AIDS (SOCA)
Investigator (1994-2000)
Age-Related Eye Disease Study
Investigator (1997-2001)
rhIGF-1 Type I Diabetes Study
Physician Investigator (1997-2000)
Complications of AMD Prevention Trial
Co-Principal Investigator (1998-2001)
Phase III Safety and Efficacy Study of Vitrase (Hyaluronidase) for Ophthalmic Intravitreal Injections for Clearance of Severe Vitreous Hemorrhage (VIT-02-08961X)
Principal Investigator (1999-2001)
Bausch&Lomb Clinical Protocol 415-001
A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide (0.5 or 2.0 mg) Implant in Patients with Non-Infectious Uveitis Affecting the Posterior Segment of the Eye.
Investigator (2001)
CUTS Study of Vitrectomy in the Management of Branch Retinal Vein Occlusion.
Investigator (2000-2004)
The Natural History of Eyes with Basal Laminar Drusen Study.
Co-Investigator (2001-2008)
Lilly Protein Kinase C Inhibitor Studies: Diabetic Retinopathy Study 2. Co-Investigator (2001-2005)
Multicenter Uveitis Steroid Treatment (MUST) Trial Implant Surgeon (2005-2007)

A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study of the Efficacy and Safety of rhuFAb V2 (Ranibizumab) Compared with Verteporfin (Visudyne) Photodynamic Therapy in Subjects with Predominately Classic Subfoveal Neovascular Age-related Macular Degeneration (Genentech Inc. & Novartis Parma AG)
Sub-investigator (2005 to 2008)
A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) in Subjects with Minimally Classic or Occult Subfoveal Neovascular Age-related Macular Degeneration (Genentech Inc. & Novartis Pharma AG)
Sub-investigator (2005 to 2008)

A Phase I/II, Single-Masked, Multicenter Study of the Safety, Tolerability, and Efficacy of Multiple-Dose Intravitreal Injections of rhuFab V2 in Combination with Verteporfin (Visudyne) Photodynamic Therapy in Subjects with Neovascular Age-Related Macular Degeneration (Genentech Inc. & Novartis Pharma AG)
Sub-investigator (2005 to 2008)
Protein Kinase C Beta Inhibitor—Diabetic Retinopathy Study Number II (PKC—DRS2) A Phase III Clinical Trial.  Protocol Number B7A-MC-MBCM.
Sub-investigator (2005)
TOGA Study: A randomized, double-masked, placebo controlled study evaluating Oracea in subjects with geographic atrophy secondary to non-exudative age-related macular degeneration. Phase II/III Study. Sub-Investigator (2013-2017)
Thrombogenis Protocol TG-MV-018: Ocriplasmin Research to Better Inform Treatment (ORBIT) Phase IV Trial. Sub-Investigator (2014-2016)
Ophthotech Protocol OPH1004A: A Phase 3 Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista (Anti PDGF-B Peglyated Aptamer) Administered in Combination with Either Avastin or Eylea Monotherapy in Subjects with Neovascular Age-Related Macular Degeneration. Sub-Investigator (2014-2016)
Genentech/Roche Protocol GX29185: A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration. Sub-Investigator (2014-2018)
Sequoia Study, Allergan Protocol Sequoia Study: A Phase III, Multicenter, Randomized, Double-Masked, Controlled Study to Assess the Efficacy and Safety of Abicipar Administered Intravitreally to Patients with Wet-Type Age Related Macular Degeneration. Principal Investigator (2016-2019)
PANDA Study, Kanghong Chengdu Protocol KHB-1801: A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-Related Macular Degeneration. Principal Investigator (2018-2019)
IMAGINE Study, Allergan Protocol 1497-301-407: Efficacy and Safety of Brimonidine Drug Delivery System (BRIMO DDS) in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Phase 3, Randonized, Double-Masked, Sham Procedure-controlled Trial Principal Investigator (2019-present)
Kodiak KSI-301P104 (Gleam Study) A Prospective, Randomized, Double-Masked, Active Comparator-controlled, Multicenter, Two-Arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared with Intravitreal Aflibercept in Participants with Visual Impairment Secondary to Treatment-naive Diabetic Macular Edema (DME). Sub-investigator (2021-present)

Pautler SE, Grizzard WS, Thompson LN, Wing GL:  Blindness from retrobulbar injection into the optic nerve: its cause, fundus picture, and prevention. Poster Presentation. American Academy of Ophthalmology 1983. Ophthal Surg 1986;17(6):334-337.
PautlerSE, Goldstein BG:  Intrastromal iris hemorrhage in a patient with hemoglobin C trait. Ann Ophthalmol 1984;16:945.
Grizzard WS, Blackshear WM, Pautler SE, Lamb S: Use of pulsed Doppler ultrasonography to evaluate blood flow in intraocular melanomas.  Presented at DESIDUO meeting in St. Petersburg, FL. November 9, 1984.
Fenske NA, Lober CW, Pautler SE: Congenital bullous urticaria pigmentosa:  Treatment with concomitant use of H1 and H2 receptor antagonists. Arch Derm 1985;121:115-118.
Pautler SE, Goldstein BG: Rhegmatogenous retinal detachment with subretinal exudates. Ann Ophthalmol 1985;17:489-493.
Pavan PR, Brinser JH, McLane NJ, Pautler SE: Treatment of endophthalmitis without systemic antibiotics.  Presented at Association for Research in Vision and Ophthalmology annual meeting, Sarasota, FL. May 6-10, 1985.

Gass JDM, Pautler SE:  Toxemia of pregnancy pigment epitheliopathy masquerading as a heredomacular dystrophy. Trans Am Ophthalmol Soc 1985; 83:114.
Pautler SE:  Fleck Retina in Kjellin’s Syndrome (letter) Am J Ophthalmol 1985,99:618-619.
Margo CE, Bullington WD, Pautler SE:  Occult suprachoroidal hemorrhage and posterior scleral rupture.  Am J Ophthalmol 1988;106:358-359.
Lewis ML, Pautler SE:  Retinal pigment epithelial detachments with neovascular membranes in age-related macular degeneration:  Natural history versus laser photocoagulation.  Published in:  Gitter KA, Schatz H, Yannuzzi LA, McDonald HR, eds.  Laser Photocoagulation of Retinal Disease.  San Francisco:  Pacific Medical Press, 1988.
Pautler SE:  Inherited retinal venous beading (letter). Am J Ophthalmol 1989;107:686.

Gass JDM, Gieser RG, Wilkinson CP, Beahm DE, Pautler SE:  Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma.  Arch Ophthalmol 1990, 108:527-533.
Margo CE, Pautler SE:  Granulomatous uveitis following treatment of choroidal melanoma with proton beam irradiation.  Retina 1990;10:140-143.
Pautler, SE. Diabetes 2000 Aims to Prevent Blindness. J Fla Med Assoc 1992 Mar; 79(3): 173-174.
Doft BH, Barza M. Optimal management of postoperative endophthalmitis and results of the Endophthalmitis Vitrectomy Study. Curr Opin Ophthalmol 1996 June;7(3):84-94.
Han DP, Wisniewski SR, Wilson LA et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996 July;122(1):1-17.
Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996;122(6):830-46.
Studies of Ocular Complications of AIDS in Collaboration with the AIDSClinical Trials Group:  Assessment of cytomegalovirus retinitis:  Clinical evaluation versus  centralized grading of fundus photographs.  Arch Ophthalmol 1996;114:791-805.
Studies of Ocular Complications of AIDS in Collaboration with the AIDS Clinical Trials Group:  Clinical vs. photographic assessment of treatment of cytomegalovirus retinitis Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Report 8. Arch Ophthalmol 1996;114:848-855.
Studies of Ocular Complications of AIDS in collaboration with the AIDS Clinical Trails Group: Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS:  The  HPMPC  Peripheral Cytomegalovirus Retinitis Trial. Ann Intern Med 1997;126:264-274.
Johnson MW, Doft BH, Kelsey SF et al. The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology 1997;104(2):261-272.
Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 1997;115(3):357-361.

Wisniewski SR, Hammer ME, Grizzard WS et al. An investigation of the hospital charges related to the treatment of endophthalmitis in the Endophthalmitis Vitrectomy Study. Ophthalmology 1997;104(5):739-745.
Barza M, Pavan PR, Doft BH et al. Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1997;115(9):1142-1150.
Doft BH, Kelsey SF, Wisniewski SR. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. Ophthalmology 1998;105(4):707-716.
Ayyala RS, Cruz DA, Margo CE, Harman LE, Pautler SE, Misch DA, Mines JA, and Richards, DW: Cystoid Macular Edema Associated with Latanoprost in Aphakic and Pseudophakic Eyes. Am J Ophthalmol 1998;126:602-604.
Aylward GW, Chang TS, Pautler SE, Gass JDM:  A Long Term Follow Up of Choroidal Osteoma. Arch Ophthalmol 1998;116:1337-1341.
Wisniewski SR, Capone A, Kelsey SF, Groer-Fitzgerald S, Lambert HM, Doft BH. Characteristics after cataract extraction or secondary lens implantation among patients screened for the Endophthalmitis Vitrectomy Study. Ophthalmology 2000 July;107(7):1274-1282.
Doft BM, Kelsey SF, Wisniewski SR. Retinal detachment in the endophthalmitis vitrectomy study. Arch Ophthalmol 2000;118(12):1661-1665.
Czajka M, Fekrat S. Vitrase ISTA Pharmaceuticals. IDrugs 2002;5(4):356-362.
Hyaluronidase (Vitrase)–ISTA: hyaluronidase–ISTA pharmaceuticals. Drugs R D 2003;4(3):194-197.
Scorolli L, Corazza D, Morara M, Vismara S, Lugaresi ML, Meduri RA. Argon laser vs. subthreshold infrared (810-nm) diode laser macular grid photocoagulation in nonexudative age-related macular degeneration. Can J Ophthalmol 2003 October;38(6):489-495.

Jacobson MA, Maecker HT, Orr PL, D’Amico R, Van Natta M, Li XD, Pollard RB, Bredt BM; Adult AIDS Clinical Trials Group and the Studies of Ocular Complications of AIDS Research Group.  Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis. J Infect Dis 2004 Apr 15; 189 (8): 1362-1373.
Marshall BC, Jacobson MA, Adler SP; Studies of Ocular Complications of AIDS Research Group, Avidity of antibodies to cytomegalovirus in HIV-seropositive patients with and without CMV retinitis. Viral Immunol 2004;17 (1): 101-108.
Kuppermann BD, Thomas EL, de S, Grillone LR. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140(4):573-584.
Kuppermann BD, Thomas EL, de S, Grillone LR. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140(4):585-97.
Cohen SM., Pautler SE, Cohen, ML, El-Jabali F.  OCT Findings in Group 2A Idiopathic Juxtafoveal Retinal Telangiectasis. Retina 2007;27:59-66.
Pautler SE. Hydroxychloroquine dosages should be calculated using lean body mass. Arch Ophthalmol 2007; 125(9):1303-1304.
Bhavsar A, Grillone L, McNamara T, Gow J, Hochberg A, Pearson R. Predicting Response Of Vitreous Hemorrhage And Outcome Of Photocoagulation After Intravitreous Injection Of Highly Purified Ovine Hyaluronidase in Patients with Diabetes. Invest Ophthalmol Vis Sci 2008 April 25.
Ying GS, Maguire MG, Liu C, Antoszyk AN. Night vision symptoms and progression of age-related Macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology 2008;115(11):1876-1862

CAPT Coordinating Center. Risk factors for Choroidal Neovascularization and Geographic Atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial. Ophthalmology 2008 Sep; 115(9): 1474-9.
Maguire MG, Alexander J, Fine SL. Characteristics of Choroidal Neovascularization in the Complications of Age-Related Macular Degeneration Prevention Trial. Ophthalmology 2008 5 Sep; 115(9): 1468-73.
Oliva AM, Pavan PR, Margo CE, Pautler SE. Recalcitrant Candida endophthalmitis associated with mannose-binding lectin deficiency. Arch Ophthalmol 2009 June;127(6):822-3.
Pautler S. Diabetic Macular Ischemia. In: Browning D, editor. Diabetic Retinopathy: Evidence Based Management. Springer; 2010. 203-25
Pautler S. Treatment of proliferative diabetic retinopathy. In: Browning D, editor. Diabetic Retinopathy: Evidence Based Management. Springer; 2010. 227-304.
Browning D, Pautler S, Telander D, Wong K, Stewart M, Bhavsar A. Clinical Examples in Managing Diabetic Retinopathy. In: Browning D, editor. Diabetic Retinopathy: Evidence Based Management. Springer; 2010. 403-39.
The Multicenter Uveitis Steroid Treatment Trial Research Group: The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics. Am J Ophthalmol 2010 April: 149:550-561.
Ying GS, Maguire MG; Complications of Age-related Macular Degeneration Prevention Trial Research Group. Development of a risk score for geographic atrophy in complications of the age-related macular degeneration preventrion trial. Ophthalmology 2011;118(2):332-338.
Davis A, Cohen SM, Pautler SE, Billiris-Findlay K, Eishenbaum DA. Beta Blocker Use and Age-Related Macular Degeneration. Acta Ophthalmologica 2013;90:232-233.

Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH; MUST Research Group. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology 2013;120(8):1571-1579.

Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorme JE, Vitale AT, Altaweel MM; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology 2013;120(9):1852-1859.

Cohen SM, Billiris-Findlay K, Eichenbaum DA, Pautler SE. Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: A Within-Patient Study. OSLI Retina 2014;45:306-310.

Pautler SE, Browning DJ. Isolated Posterior Uveal Effusion: Expanding the spectrum of the uveal effusion syndrome. Clin Ophthalmol 2014;9:43-49.
http://www.dovepress.com/isolated-posterior-uveal-effusion-expanding-the-spectrum-of-the-uveal–peer-reviewed-article-OPTH

Wong KE, Pautler SE, Browning DJ. Near-infrared reflectance bull’s eye maculopathy as an early indication of hydroxychloroquine toxicity. Clin Ophthalmol 2014;9:521-525.

Pautler SE, Cohen SM, Findlay KB, Eichenbaum DA, Lopez M. Clinical findings of the posterior uveal effusion syndrome. American Academy of Ophthalmology Poster Presentation PO476, Chicago. October, 2015.

Xu D, Garg E, Lee K, Sakurada Y, Amphornphruet A, Phasukkijwatana, N, Liakopoulos S, Pautler SE, Kreiger AE, Yzer S, Lee WK, Sadda SR, Freund KB, Sarraf D. Long term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome. Br J Ophthalmol 2020 Dec 21:bjophthalmol-2019-315550. Online ahead of print.